Researchers in Naples found tiny plastic particles in the coronary blood of most patients suffering severe heart attacks, a discovery that raises fresh questions about an environmental threat hiding in plain sight.
A team led by Dr. Raffaele Marfella at the University of Campania Luigi Vanvitelli drew blood directly from the coronary arteries of 61 patients undergoing angiograms, the imaging procedure doctors use to check for blocked heart vessels. The results, published in the European Heart Journal, split sharply along one line: how sick the patient was. Nearly 84 percent of those in the grip of an active, severe heart attack carried detectable micro- and nanoplastics in their blood. Among patients with chronic heart disease, the figure dropped to 40 percent. Among those whose arteries looked normal, it fell to 32 percent.
The gap is striking. So is the type of plastic involved. Polyethylene, the material in grocery bags, food wrap, and disposable water bottles, turned up in 97 percent of patients who tested positive. And the single strongest predictor of whether plastic particles showed up at all was not diet or geography. It was smoking.
Newsmax reported that smokers were six times more likely than nonsmokers to have microplastics circulating in their bloodstream. Smokers who also lived with higher air pollution registered a perfect hit rate, every one of them had plastics in their blood.
That finding complicates any simple narrative. Smoking and dirty air are already well-established drivers of heart disease. Disentangling the independent effect of plastic particles from those risks is exactly the kind of work this study was too small to do on its own.
Michelle Routhenstein, a preventive cardiology dietitian at EntirelyNourished.com in New York City who was not involved in the research, told Fox News Digital:
"Factors like smoking and air pollution are also linked to cardiovascular disease and higher plastic exposure, making it difficult to separate the independent effects of microplastics."
She added a broader caution about drawing conclusions from a single data set:
"This was an observational study, so it can only show an association, not cause and effect. It also included a relatively small group of patients from one country, so we can't assume the findings apply to everyone."
The Italian study did not land in a vacuum. Previous research, described by Routhenstein as part of "emerging research showing the potential role of micro- and nanoplastics in heart disease", had already detected microplastics lodged in arterial plaque itself.
A separate small Italian study, reported by the Associated Press, examined 257 patients who had surgery for blocked blood vessels in the neck. Researchers found micro- and nanoplastics embedded in the arterial plaque of 150 of them. Over three years of follow-up, 20 percent of patients with plastics in their arteries suffered a heart attack, stroke, or died, compared to roughly 8 percent of those whose plaque was plastic-free. Patients carrying plastics also showed more inflammation, a condition long linked to elevated cardiac risk.
Dr. Steve Nissen of the Cleveland Clinic called that earlier work "a wake-up call."
"As a cause for heart disease? Not proven. As a potential cause? Yes, maybe."
Dr. Philip Landrigan of Boston College went further, saying the research "does not prove cause and effect, but it suggests cause and effect. And it needs urgently to be either replicated or disproven by other studies done by other investigators in other populations."
The new Marfella study drew attention beyond the lab. An accompanying editorial in the European Heart Journal, authored by Professor Emanuele Barbato of Sapienza University of Rome, framed the findings in blunt terms. As the New York Post reported, Barbato wrote:
"These findings do not prove that microplastics cause heart attacks, but they reveal a strong association between environmental exposures, microplastics in the blood and cardiovascular disease."
He added that "plastic pollution may represent a previously underestimated cardiovascular risk factor."
That language, "underestimated", carries weight coming from a peer-reviewed cardiology journal, not an activist group. It signals that the medical establishment is beginning to treat microplastics as something more than a curiosity confined to marine biology papers.
Washington has started to respond. HHS Secretary Robert F. Kennedy Jr. and EPA Administrator Lee Zeldin announced a new initiative aimed at removing microplastics from the food supply and the broader environment. Both officials discussed the effort in an exclusive interview with Fox News senior medical analyst Dr. Marc Siegel.
Details of the initiative beyond the announcement remain thin. But the timing aligns with a growing body of research, including the Marfella study, that puts microplastics squarely in the public-health conversation rather than on the margins.
Routhenstein offered straightforward advice for anyone looking to cut their own exposure. She recommended replacing plastic food containers with glass, avoiding microwaving food in plastic, and limiting single-use plastic bottles, especially in heat, which accelerates the breakdown of plastic into smaller particles.
"Think of reducing plastic exposure as one piece of an overall heart-healthy lifestyle."
None of that requires a government program or a new regulation. It requires a trip to the kitchen cabinet.
Sixty-one patients in one Italian hospital do not settle a scientific question. The study did not control for every confounding variable. It did not track patients over time. It did not establish a mechanism by which plastic particles might trigger or worsen a heart attack. And the researchers did not report specific concentrations of plastic, only whether particles were detectable.
Those are real limitations. But dismissing the findings because the sample was small misses the pattern. Two separate Italian research teams, using different patient populations and different methods, have now linked micro- and nanoplastics to worse cardiovascular outcomes. The earlier study on arterial plaque followed patients for three years and found a measurable difference in heart attacks, strokes, and deaths.
The question is no longer whether these particles end up inside the human body. They do. The question is what they do once they get there, and whether anyone in a position of authority will fund the larger, longer studies needed to find out before the next round of results arrives from a hospital in Naples.
Americans have spent decades being told which fats to eat, which chemicals to avoid, and which drugs to take. They deserve the same urgency applied to the plastic lining their takeout containers.
